Publications by authors named "Burak Kulaksizoglu"

Introduction: The study aims to compare childhood traumas, attachment styles, impulsivity, and quality of life of Opioid Use Disorder (OUD) patients in remission with healthy controls and to reveal the relationships between these parameters.

Methods: The study included one hundred patients diagnosed with OUD and one hundred healthy volunteers. Sociodemographic data form, Structured Clinical Interview for DSM-5 Disorders Clinician Version, Childhood Trauma Questionnaire, Relationship Scales Questionnaire, Barratt Impulsivity Scale-11, World Health Organization Quality of Life Scale Brief Version and Substance Craving Scale were administered.

View Article and Find Full Text PDF

Objective: To investigate the frequency of bruxism, factors associated with bruxism and sleep disorders in patients diagnosed with depressive disorder and anxiety disorder who use antidepressants.

Methods: A total of 273 patients diagnosed with anxiety disorder or depression who had been using antidepressants for at least 1 month were included, along with 273 healthy control groups. The patient and control groups completed a sociodemographic data form, Epworth Daytime Sleepiness Scale (EDSS), Pittsburgh Sleep Quality Index (PSQI) and a bruxism questionnaire.

View Article and Find Full Text PDF

Aim: To compare opioid use disorder (OUD) patients who continue to use opioids and are in remission with buprenorphine-naloxone (B/N) in terms of some parameters and to evaluate the relationship between B/N dose and these parameters.

Method: We included 141 OUD patients in remission with B/N maintenance treatment for at least 6 months, 141 who still used opioids, and 141 healthy volunteers. Substance Craving Scale (SCS), Pittsburgh Sleep Quality Index (PSQI), Arizona Sexual Experiences Scale (ASEX), and Short Form 36 (SF-36) were administered.

View Article and Find Full Text PDF

Background: It was aimed to compare childhood traumas, relationship satisfaction, sexual functions, and love attitudes in depressive disorder (DD) patients with healthy volunteers.

Subjects And Methods: The study included 100 DD patients, who were in remission and had no drug side effects, and 100 healthy volunteers. A sociodemographic data form, the Childhood Trauma Questionnaire (CTQ), the Love Attitudes Scale (LAS), the Relationship Assessment Scale (RAS), and the Arizona Sexual Experiences Scale (ASEX) were administered to all participants.

View Article and Find Full Text PDF

Background: Hepatitis C virus (HCV) infection is very common in people who inject drugs (PWID). Studies about the prevalence and genotype distribution of the HCV among PWID are very crucial for developing strategies to manage HCV infection. This study's objective is to map the distribution of HCV genotypes among PWID from various regions of Turkey.

View Article and Find Full Text PDF

Objective: We aimed to compare the effectiveness of extended-release naltrexone (XR-NTX) implant and sublingual buprenorphine-naloxone (BUP-NX) in relapse prevention in opiate use disorder (OUD).

Methods: Medical records of 400 patients who were treated for OUD between 2016 and 2020 were retrospectively evaluated concerning sociodemographic and clinical characteristics and abstinence duration with either BUP-NX (192 patients) or XR-NTX (208 patients) as maintenance treatments.

Results: The median age of patients using BUP-NX was 25.

View Article and Find Full Text PDF
Article Synopsis
  • Opioid misuse and dependence, a global issue, is addressed with Buprenorphine/naloxone (BNC), a drug that reduces opioid cravings and is safer than full agonists.
  • BNC combines buprenorphine, a partial agonist, with naloxone, an antagonist that prevents misuse through intravenous diversion, making it suitable for detoxification and maintenance in opioid dependence.
  • The article discusses a case of a monitored patient misusing BNC intravenously alongside oral pregabalin, which is also becoming known for its potential misuse.
View Article and Find Full Text PDF

Introduction: The aim of our study was to evaluate the relationship between neutrophil/lymphocyte ratio (NLR) and total antioxidant status (TAS), total oxidative status (TOS), oxidative stress index (OSI), paraoxonase, and total thiol (T.thl) in schizophrenic patients compared to healthy control group and investigate the relationship between these parameters and psychopathological symptoms.

Methods: The study population consisted of 61 healthy control subjects and 64 volunteer patients monitored in the outpatient clinics of psychiatry of Antalya Education and Research Hospital.

View Article and Find Full Text PDF

Depression and anxiety are both known to be co-morbid with coronary heart disease. Given the high prevalence of coronary heart disease today, specifically the aspect of hypertension, it seems more important than ever to investigate whether or not treatment of these co-morbidities can have an effect on reducing hypertension. This article summarizes the limited amount of literature that has been published in this area and highlights what we believe to be a missing key element that will guide our own future research in this area.

View Article and Find Full Text PDF

Depression and coronary heart disease (CHD) are significant contributors to the burden of disease in both developed and developing countries. Although depression seems to be a marker of increased risk after the diagnosis of CHD, it is currently unclear whether depression can be considered as an independent risk factor and whether its treatment lowers the risk. We review the data from prominent trials and recent analyses in regard to the association of depression with CHD.

View Article and Find Full Text PDF

Anorexia nervosa is a rare psychiatric disorder and epidemiological studies have shown a female to male ratio of 10:1, suggesting it is a disorder predominantly seen among females. The prevalence of anorexia nervosa comorbid with other psychiatric disorders has been reported to be quite high. Whereas depression and anxiety disorders are the most common comorbid diagnoses in anorexic patients, the dual-diagnosis of anorexia and schizophrenia is a relatively rare condition.

View Article and Find Full Text PDF